Cash Cash Equivalents - Cyclopharm Ltd (ASX:CYC) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 1.435 AUD 3.99%

Updated:

Cyclopharm Ltd
Cash & Cash Equivalents

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Cyclopharm Ltd
Cash & Cash Equivalents Peer Comparison

NTI

IPD

COH

OIL

EMV

Company		Cash & Cash Equivalents	CAGR 3Y	CAGR 5Y	CAGR 10Y
C	Cyclopharm Ltd ASX:CYC	Cash & Cash Equivalents AU$11.7m	CAGR 3-Years 84%	CAGR 5-Years 15%	CAGR 10-Years 25%
	Neurotech International Ltd ASX:NTI	Cash & Cash Equivalents AU$4.5m	CAGR 3-Years 30%	CAGR 5-Years 59%	CAGR 10-Years N/A
	ImpediMed Ltd ASX:IPD	Cash & Cash Equivalents AU$36.9m	CAGR 3-Years 25%	CAGR 5-Years 10%	CAGR 10-Years 23%
	Cochlear Ltd ASX:COH	Cash & Cash Equivalents AU$485.2m	CAGR 3-Years -6%	CAGR 5-Years 39%	CAGR 10-Years 23%
	Optiscan Imaging Ltd ASX:OIL	Cash & Cash Equivalents AU$8.7m	CAGR 3-Years -2%	CAGR 5-Years 53%	CAGR 10-Years 38%
	EMvision Medical Devices Ltd ASX:EMV	Cash & Cash Equivalents AU$9.7m	CAGR 3-Years 21%	CAGR 5-Years 57%	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Cash & Cash Equivalents amounts to 11.7m AUD.

Over the last year, the Cash & Cash Equivalents growth was -42%. The average annual Cash & Cash Equivalents growth rates for Cyclopharm Ltd have been 84% over the past three years , 15% over the past five years , and 25% over the past ten years .

Join more than 142,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.